We will contact you shortly. In the meantime, check out our social media and latest publications

    • The latest from Median

    Business Intelligence-based reporting optimizes the operational efficiency of clinical trial imaging services
    Read more
    New results, obtained on a very large cohort of 9,863 patients show drastically improved performance of the iBiopsy® LCS CADe/CADx Software as Medical Device (SaMD) with a sensitivity of 96.5% at a specificity of 97.2%.
    Read more
    urther to the Q-submission phase completion, Median’s iBiopsy® LCS CADe/CADx SaMD pivotal study protocols are now finalized and ready for study execution.
    Read more
    Our webinar replay is available here: Decentralized Clinical Trials: The patient-centric future of oncology R&D?
    Read more
    Watch our video: iCRO Imaging Services for Clinical Trials in Oncology
    Watch
    Watch our video: iBiopsy®, enhancing imaging diagnostic accuracy
    Watch

    Webinars

    Decentralized Clinical Trials: The patient-centric future of oncology R&D?

    Full or Hybrid DCT? What is the best fit when it comes to oncology research, the role of clinical trial imaging with these models, and how do you ensure success? Watch this webinar replay to gain insight into DCT strategies and tools to consider for your next oncology trial.

    Know more
    See all webinars
    Insights